Behaviors of Turkish pregnant women towards gestational diabetes screening

Abstract

Objectives: Although gestational diabetes is the most common metabolic disease in pregnancy some pregnant women still refuse to undergo oral glucose tolerance test (OGTT). The purpose of this study was to evaluate the behavior of pregnant women undergoing OGTT, and to compare perinatal results between women who undergo and refuse OGTT.
 Methods: This retrospective cohort study was performed by evaluating the data of Izmir Katip Celebi University Gynecology and Obstetrics outpatient clinic between 2012-2017. Data of 2079 pregnant were evaluated retrospectively. Among 373 women who refused OGTT were evaluated as the study group, while remaining 1706 women who underwent OGTT were considered as the control group. The groups were compared with regard to perinatal results.
 Results: Sixty-two point four percent of the group who refused OGTT had a C-section, while 56.3% of the control group had a C-section (p<0.05). Intrauterine growth retardation, fetal distress, amniotic fluid pathologies, macrosomia, gestational hypertension and perinatal death were slightly higher in pregnant women who did not undergo OGTT compared to the control group, however, the difference was not statistically significant.
 Conclusion: Maternal complications and poor pregnancy results were found slightly higher in pregnant women who refused OGTT. These results might be explained by assuring glycemic control in pregnant women who refused OGTT by a series of fasting and postprandial blood sugar measurements in our center.
 doi: https://doi.org/10.12669/pjms.37.5.4176
 How to cite this:Aydogmus H, Aydogmus S, Tiras HI, Cankaya Z . Behaviors of Turkish pregnant women towards gestational diabetes screening. Pak J Med Sci. 2021;37(5):---------. doi: https://doi.org/10.12669/pjms.37.5.4176
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Is maternal serum endocan level a novel marker in gestational diabetes mellitus?

“…28 Furthermore, the prevalence is increasing (5%-20%) worldwide, accordingly, the importance of GDM screening is becoming more crucial in predicting and evaluating co-morbidities 4 Macrosomia, shoulder dystocia, large for gestational age, small for gestational age, cesarean delivery, preterm birth, respiratory distress syndrome (RDS), hypoglycemia, hypocalcemia, hyperbilirubinemia, and congenital anomalies are the some of the medical problems that the neonate of a pregnant woman with GDM may experience 29 comorbidities, developing T2DM is a known risk for patients with a history of GDM, and they also have a two-fold increased risk for cardiovascular diseases. 30 In a study by Hussein et al, 31 a group that refused to undergo GDM scan (GCT or OGTT-any oral glucose taking) and a group that had GDM scan were evaluated in terms of perinatal outcomes. In the group that refused GDM scan, higher cesarean rates, more intrauterine growth retardation, fetal distress, amniotic fluid pathologies, macrosomia, gestational hypertension, and more perinatal deaths were determined.…”

“…In a study by Hussein et al, 31 a group that refused to undergo GDM scan (GCT or OGTT‐any oral glucose taking) and a group that had GDM scan were evaluated in terms of perinatal outcomes. In the group that refused GDM scan, higher cesarean rates, more intrauterine growth retardation, fetal distress, amniotic fluid pathologies, macrosomia, gestational hypertension, and more perinatal deaths were determined.…”

Oral glucose tolerance test in pregnancy: questions and answers

“…Другая часть считают, что выполнение ПГТТ необязательно, ссылаясь на неосложненное течение предыдущей беременности. Кроме того, некоторые пациентки отмечают, что не выполнили ПГТТ, т. к. их доктор им этого не рекомендовал или они слышали негативную информацию о ПГТТ из источников массмедиа [16]. Среди иных причин отказа от тестирования пациентки указывали плохую транспортную доступность медицинских центров, сложность в посещении множества визитов к врачу [15].…”

“…Самой распространенной причиной отказа от ПГТТ является тошнота и рвота [13][14][15][16][17]. Часть пациентов не может выполнить тест по причине тяжелой переносимости гиперосмолярного раствора глюкозы.…”